NCT01393730 Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01393639 Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01390584 Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT01378091 Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE1
NCT01376401 Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01375140 Ruxolitinib and Lenalidomide for Patients With Myelofibrosis Status COMPLETED Phase PHASE2
NCT01371630 Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT01369745 A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01364389 A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica Status TERMINATED Phase PHASE2
NCT01359592 S1001 PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT01358253 Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT01356511 High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE4
NCT01349270 Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg Status COMPLETED Phase PHASE3
NCT01342016 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients Status TERMINATED Phase PHASE3
NCT01336933 Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01335685 Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01334502 Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01332968 A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) Status COMPLETED Phase PHASE3